Chapter

Pharmacotherapy for Autism Spectrum Disorders

James T. McCracken

in Autism Spectrum Disorders

Published on behalf of Oxford University Press

Published in print May 2011 | ISBN: 9780195371826
Published online September 2012 | e-ISBN: 9780199965212 | DOI: http://dx.doi.org/10.1093/med/9780195371826.003.0085
Pharmacotherapy for Autism Spectrum Disorders

More Like This

Show all results sharing these subjects:

  • Child and Adolescent Psychiatry
  • Neurology
  • Neuroscience

GO

Show Summary Details

Preview

Children, adolescents, and adults with the full range of the autism spectrum disorders (ASDs) are frequently referred for possible pharmacologic treatment for an array of associated difficult-to-manage behaviors, and to support adaptation and progress from other forms of interventions. This chapter reviews the available evidence for each of the major drug classes, as well as information regarding their safety and optimal use. It discusses current recommendations based on the best evidence available for the largest and most commonly presented targets for treatment in individuals with ASDs. Finally, it describes future directions for drug development in ASDs based on emerging models of etio-pathophysiology of ASDs and related conditions.

Chapter.  10923 words.  Illustrated.

Subjects: Child and Adolescent Psychiatry ; Neurology ; Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.